Basilea Pharmaceutica Ag (0QNA)
LSE
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current 0QNA market cap is 554.49M. The company's latest EPS is CHF 0.8708 and P/E is 53.05.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 114.79M | 112.42M | 131.56M | 122.32M | 150.28M |
| Operating Income | -17.2M | -23.26M | 1.17M | 18.54M | 19.21M |
| Net Income | -22.42M | -14.72M | -6.83M | 12.15M | 10.45M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 221.47M | 229.79M | 247.27M | 220.85M | 173.29M |
| Total Liabilities | 314.43M | 331.84M | 305.87M | 241.56M | 183.29M |
| Total Equity | -92.96M | -102.05M | -58.61M | -20.72M | -10M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | -63.84M | -54.13M | -32.02M | 7.06M | 14.25M |
| Investing | -404k | -34.96M | 3.58M | 91.65M | -1.03M |
| Financing | 1.31M | 45.07M | 16.64M | -45.25M | -57.31M |
| Market Cap | 554.49M |
| Price to Earnings Ratio | 53.05 |
| Price to Sales Ratio | 3.69 |
| Price to Cash Ratio | 9.25 |
| Price to Book Ratio | -55.44 |
| Dividend Yield | - |
| Shares Outstanding | 12M |
| Average Volume (1 week) | 163 |
| Average Volume (1 Month) | 7.85k |
| 52 Week Change | 0.00% |
| 52 Week High | 46.20 |
| 52 Week Low | 46.20 |
| Spread (Intraday) | 2.3 (4.86%) |
| Company Name | Basilea Pharmaceutica Ag |
| Address |
grenzacherstrasse 487 basel 4058 |
| Website | https://www.basilea.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
